Skip to Main Content

Advertisement

First Edition

Brief Report January 21 2020
Baseline SUVmax did not predict histological transformation in the phase 3 GALLIUM study in follicular lymphoma
Brief Report January 21 2020
Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions
Letter January 21 2020
Long-term outcomes of Sleeping Beauty generated CD19specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
Research Article January 21 2020
Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations
Research Article January 21 2020
How I treat measurable (minimal) residual disease in acute leukemia after allogeneic hematopoietic cell transplantation
Research Article January 21 2020
Progressive or Relapsed Burkitt Lymphoma or Leukemia in Children and Adolescents after BFM-type First-line Therapy
Research Article January 17 2020
How I assess and manage the risk of bleeding during treatment of patients with venous thromboembolism
Research Article January 17 2020
Bi-specific and Split CAR T Cells Targeting CD13 and TIM3 Eradicate Acute Myeloid Leukemia
Letter January 17 2020
Multiple BCL2 mutations co-occurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
Brief Report January 17 2020
Acetylsalicylic acid (ASA) inhibits intravascular coagulation during S. aureus-induced sepsis in mice
Research Article January 17 2020
NADPH oxidase controls pulmonary neutrophil infiltration in the response to fungal cell walls by limiting LTB4
Brief Report January 17 2020
Targeting Myeloid-Cell Specific Integrin α9β1 Inhibits Arterial Thrombosis in Mice
Research Article January 16 2020
Rapid and Accurate Bayesian Diagnosis of Heparin-induced thrombocytopenia
Research Article January 16 2020
Brentuximab vedotin with chemotherapy for Stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
Editorial January 15 2020
Introduction to a Review Series on Understanding and Treating Primary Immunodeficiency
Review Article January 15 2020
Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency
Review Article January 15 2020
Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection
Review Article January 15 2020
Virus specific T-cell Therapies for Patients with Primary Immune Deficiency
Review Article January 15 2020
Current Genetic Landscape in Common Variable Immune Deficiency
Review Article January 15 2020
Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.
Review Article January 15 2020
A Research-Driven Approach to the Identification of Novel Natural Killer Cell Deficiencies Affecting Cytotoxic Function
Research Article January 14 2020
High-Parametric Evaluation of Human Invariant Natural Killer T Cells to Delineate Heterogeneity in Allo- and Autoimmunity
Letter January 14 2020
Molecular dynamics during reduction of TKI dose reliably identify molecular recurrence after treatment cessation in CML
Research Article January 13 2020
IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution
Research Article January 13 2020
Improved transplant survival and long-term disease outcome in children with MHC class II deficiency
Research Article January 13 2020
External Validation of Models for KIR2DS1/KIR3DL1-informed Selection of Hematopoietic Cell Donors fails
Research Article January 13 2020
Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study
Research Article January 13 2020
Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis
Letter January 13 2020
Prevalence and disease predisposition of p.A91V perforin in an aged Caucasian population
Research Article January 13 2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
Research Article January 13 2020
Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab
Review Article January 9 2020
Managing Thromboembolic Risk in Patients with Hereditary and Acquired Thrombophilias
Review Article January 9 2020
Novel Antithrombotic Strategies for Treatment of Venous Thromboembolism
Review Article January 9 2020
ACUTE TREATMENT OF VENOUS THROMBOEMBOLISM
Review Article January 9 2020
Treatment of unusual thrombotic manifestations
Editorial January 9 2020
Introduction to a review series on the treatment of venous thrombotic disorders
Review Article January 9 2020
Treatment of venous thromboembolism in pediatric patients
Review Article January 9 2020
Long-term treatment of venous thromboembolism
Letter January 8 2020
Ticagrelor causes false negative functional tests for heparin-induced thrombocytopenia
Research Article January 8 2020
Nivolumab treatment for relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistocytosis in adults
Research Article January 3 2020
How I Treat: Selecting CD19 Targeted Immunotherapies in Adult Patients with Advanced Acute Lymphoblastic Leukemia
Research Article January 3 2020
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
Letter January 2 2020
Achieving Complete Remission in CLL Patients Treated with Ibrutinib: Clinical Significance and Predictive Factors
Research Article January 2 2020
How I treat Anemia in Heart Failure
Brief Report December 27 2019
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia patients treated in the ALFA0701 trial
Research Article December 27 2019
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T Cells Promote Indirect Alloantigen Presentation in the GI Tract during GVHD
Research Article December 26 2019
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
Research Article December 26 2019
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study
Brief Report December 23 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer. A case-control study.
Research Article December 19 2019
Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity
Page 1 of 2
Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal

Advertisement

X